News
Aspirin May Be A Risk-Reducer for Breast Cancer Survivors
“Chalk up another use for aspirin: The drug appears to substantially reduce breast cancer survivors’ risk of metastasis and death, researchers found.
“An aspirin at least two days a week significantly reduced breast cancer death risk by 64% to 71%, Michelle D. Holmes, MD, DrPH, of the Channing Laboratory at Harvard and Brigham and Women’s Hospital in Boston, and colleagues reported online in the Journal of Clinical Oncology.
“The risk reduction for distant metastasis in breast cancer survivors taking aspirin at least two days a week was a significant 43% to 60% in the analysis of the Nurses’ Health Study data through 2006.
“This cut the risk of death from any cause nearly in half, Holmes’ group noted.”
Source: Medpage Today, February 16, 2010
Citation: Journal of Clinical Oncology, 2010; 28.
